Trace elements, magnesium, and the efficacy of antioxidant systems in children with type 1 diabetes mellitus and in their siblings

Advances in Clinical and Experimental Medicine

Volumn 23, Issue 2, 2014, Pages 259-268

  Salmonowicz, Barbara ^a   Krzystek Korpacka, Małgorzata ^a   Noczyńska, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Antioxidant enzymes; Magnesium; TAS; Trace elements; Type 1 diabetes mellitus

Indexed keywords

ANTIOXIDANT; CATALASE; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; HEMOGLOBIN A1C; MAGNESIUM; MANGANESE; SELENIUM; ZINC; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; COPPER BLOOD LEVEL; DEFENSE MECHANISM; DISEASE DURATION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MANGANESE BLOOD LEVEL; MEDICAL SOCIETY; METABOLIC PARAMETERS; SELENIUM BLOOD LEVEL; SIBLING; SLOVENIA; ZINC BLOOD LEVEL; ADOLESCENT DISEASE; CHOLESTEROL BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; ANTIOXIDANTS; CATALASE; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; COPPER; DIABETES MELLITUS, TYPE 1; ERYTHROCYTES; FEMALE; HUMANS; MAGNESIUM; MALE; SELENIUM; SIBLINGS; TRACE ELEMENTS; ZINC;

EID: 84902199642     PISSN: 18995276     EISSN: None     Source Type: Journal    
DOI: 10.17219/acem/37074     Document Type: Article

References (53)

1. Brownlee M: The pathobiology of diabetic complication: a unifying mechanism. Diabetes 2005, 54, 1615-1626.
2. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A: Biomarkers of oxidative damage in human disease. Clin Chem 2006, 52, 601-623.
3. Telci A, Cakatay U, Salman S, Satman I, Sivas A: Oxidative protein damage in early stage Type 1 diabetic patients. Diab Res Clin Pract 2000, 50, 213-223.
4. Erciyas F, Taneli F, Arslan B, Uslu Y: Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus. Arch Med Res 2004, 35, 134-140. (Pubitemid 38316832)
5. Gil-del Valle L, de las C Milian L, Toledo A, Vilaró N, Tápanes R, Otero MA: Altered redox status in patients with diabetes mellitus type 1. Pharmacol Res 2005, 51, 375-380.
6. Martín-Gallán P, Carrascosa A, Gussinye M, Domínguez C: Estimation of lipoperoxidative damage and antioxidant status in diabetic children: relationship with individual antioxidants. Free Radic Res 2005, 39, 933-942.
7. Seckin D, Ilhan N, Ilhan N, Ertugrul S: Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1 diabetes mellitus. Diab Res Clin Pract 2006, 73, 191-197. (Pubitemid 43928152)
8. Valko M, Morris H, Cronin MT: Metals, toxicity, and oxidative stress. Curr Med Chem 2005, 12, 1161-1208.
9. Franz MJ, Bantle JP, Beebe CA: Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002, 25, 148-198.
10. Holmgren A: Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid Redox Signal 2000, 2, 811-820.
11. Chan S, Gerson B, Subramaniam S: The role of copper, molybdenum, selenium, and zinc in nutrition and health. Clin Lab Med 1998, 18, 673-685. (Pubitemid 28531294)
12. Nordberg J, Arnér ES: Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001, 31, 1287-1312. (Pubitemid 33145299)
13. Gutteridge JM: Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995, 41, 1819-1828.
14. Bartosz G: The second face of oxygen. Free radicals in nature. Wyd. Nauk. PWN, Warszawa 2004.
15. Tapiero H, Tew KD: Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed Pharmacother 2003, 57, 399-411. (Pubitemid 37498214)
16. Kruse-Jarres JD, Rükgauer M: Trace elements in diabetes mellitus. Peculiarities and clinical validity of determinations in blood cells. J Trace Elem Med Biol 2000, 14, 21-27. (Pubitemid 30323942)
17. Everett CJ. King DE: Serum magnesium and the development of diabetes. Nutrition 2006, 22, 679.
18. Walter RM, Uriu-Hare JY, Olin KL: Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 1991, 14, 1050-1056.
19. Sales CH, Pedrosa Lde F: Magnesium and diabetes mellitus: their relation. Clin Nutr 2006, 25, 554-562. (Pubitemid 44109076)
20. Djurhuus MS, Klitgaard NAH, Pedersen KK: Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes. Metabolism 2001, 50, 1409-1417. (Pubitemid 34007409)
21. Abou-Seif MA, Youssef AA: Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 2004, 346, 161-170. (Pubitemid 38901047)
22. McNair P, Christensen MS, Christiansen C, Madsbad S, Transbøl I: Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Invest 1982, 12, 81-85. (Pubitemid 12190480)
23. Bjelakovic G, Sokolovic D, Ljiljana S: Arginase activity and magnesium levels in the blood of children with diabetes mellitus. J Basic Clin Physiol Pharmacol 2009, 20, 319-334.
24. Guerrero-Romero F, Rodríguez-Morán M: Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch Med Res 2005, 36, 250-257. (Pubitemid 40755138)
25. Atabek ME, Kurtoglu S, Pirgon O, Baykara M: Serum magnesium concentrations in type 1 diabetic patients: relation to early atherosclerosis. Diab Res Clin Pract 2006, 72, 42-47.
26. Navarro-Alarcón M, López-G de la Serrana H, Pérez-Valero V, López-Martínez C: Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus. Sci Total Environ 1999, 228, 79-85. (Pubitemid 29179532)
27. Ruíz C, Alegría A, Barberá R, Farrd R, Lagarda J: Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states. J Trace Elem Med Biol 1998, 12, 91-95. (Pubitemid 28380236)
28. Iwanicka Z, Kotschy B, Wa̧sikowa R: Serum selenium concentrations in type 1 diabetic patients. Endo Diab 1997, 3, 105-110.
29. Dahlquist G: Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis. Diabetologia 2006, 49, 20-24.
30. Mowri HO, Frei B, Keaney JF Jr: Glucose enhancement of LDL oxidation is strictly metal ion dependent. Free Radic Biol Med 2000, 29, 814-824.
31. Shukla N, Maher J, Masters J, Angelini GD, Jeremy JY: Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor? Atherosclerosis 2006, 187, 238-250. (Pubitemid 43963031)
32. Ehrenwald E, Chisolm GM, Fox PL: Intact human ceruloplasmin oxidatively modifies low-density lipoprotein. J Clin Invest 1994, 93, 1493-1501. (Pubitemid 24116385)
33. Awadallah SM, Hamad M, Jbarah I, Salem NM, Mubarak MS: Autoantibodies against oxidized LDL correlate with serum concentrations and ceruloplasmin in patients with cardiovascular disease. Clin Chim Acta 2006, 365, 330-336. (Pubitemid 43196456)
34. Bügel S, Harper A, Rock E, O'Connor JM, Bonham MP, Strain JJ: Effect of copper supplementation on indices of copper status and certain CVD risk markers in young healthy women. Br J Nutr 2005, 94, 231-236. (Pubitemid 41357794)
35. Rohn RD, Pleban P, Jenkins LL: Magnesium, zinc and copper in plasma and blood cellular components in children with IDDM. Clin. Chim. Acta 1993, 215, 21-28. (Pubitemid 23138509)
36. Ruíz C, Alegría A, Barberá R, Farré R, Lagarda J: Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states. J Trace Elem Med Biol 1998, 12, 91-95. (Pubitemid 28380236)
37. Leonhardt W, Hanefeld M, Müller G: Impact of concentrations of glycated hemoglobin, alpha-tocopherol, copper and manganese on oxidation of low-density lipoproteins in patients with type I, type II diabetes and control subjects. Clin Chim Acta 1996, 254, 173-186. (Pubitemid 26325566)
38. Mezzetti A, Pierdomenico SD, Costantini F: Copper/zinc ratio and systemic oxidant load: effect of aging and aging-related degenerative diseases. Free Radic Biol Med 1998, 25, 678-681.
39. Robertson RP: Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004, 279, 42351-42354.
40. Tiedge M, Steffeck H, Elsner M, Lenzen S: Metabolic regulation, activity state, and intracellular binding of glucokinase in insulin-secreting cells. Diabetes 1999, 48, 514-532.
41. Tanaka Y, Tran PO, Harmon J: A role for glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci USA 2002, 99, 12363-12368.
42. Zivić S, Vlaski J, Kocić G, Pesić M, Cirić V, Durić Z: The importance of oxidative stress in the pathogenesis of type 1 diabetes-determination of catalase activity in lymphocytes of diabetic patients. Med Pregl 2008, 61, 458-463.
43. Chiarelli F, Santilli F, Sabatino G: Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. Pediatr Res 2004, 56, 720-725. (Pubitemid 39403396)
44. Domínguez C, Ruiz E, Gussinye M, Carrascosa A: Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 1998, 21, 1736-1742. (Pubitemid 28449817)
45. Ruiz C, Alegría A, Barberá R, Farré R, Lagarda MJ: Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest 1999, 59, 99-105.
46. Elhadd TA, Khan F, Kirk G, McLaren M: Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes. Diabetes Care 1998, 21, 1990-1996. (Pubitemid 28478306)
47. Varvarovská J, Racek J, Stozický F, Soucek J, Trefil L, Pomahacová R: Parameters of oxidative stress in children with type 1 diabetes mellitus and their relatives. J Diabetes Complications 2003, 17, 7-10.
48. Astaneie F, Afshari M, Mojtahedi A: Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res 2005, 36, 376-381. (Pubitemid 40798392)
49. Marra G, Cotroneo P, Pitocco D: Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care 2002, 25, 370-375. (Pubitemid 41079638)
50. Valabhji J, McColl AJ, Richmond W, Schachter M, Rubens MB, Elkeles RS: Total antioxidant status and coronary artery calcification in type 1 diabetes. Diabetes Care 2001, 24, 1608-1613. (Pubitemid 33716457)
51. Vantyghem MC, Balduyck M, Zerimech F: Oxidative markers in diabetic ketoacidosis. J Endo Invest 2000, 23, 732-736. (Pubitemid 32041052)
52. Reis JS, Bosco AA, Veloso CA, Mattos RT, Purish S, Nogueira-Machado JA: Oxidizing and reducing responses in type 1 diabetic patients determined up to 5 years after the clinical onset of the disease. Acta Diabetol 2008, 45, 221-224.
53. Matteucci E, Giampietro O: Building a bridge between clinical and basic research: the phenotypic elements of familial predisposition to type 1 diabetes. Curr Med Chem 2007, 14, 555-567. (Pubitemid 46477728)